Fundraising Fox
Abilita Therapeutics
San Diego, US · Founded 2019 · 1 known investors
Find your way into Abilita Therapeutics
Sign up to see every warm intro you have to Abilita Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Abilita Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Abilita Therapeutics is a drug discovery company focused on membrane protein targets, using its EMP (Enabled Membrane Proteins) technology based on directed evolution to create stability- and expression-enhanced protein variants for discovering and optimizing drug candidates.
Founders & leadership
Abilita Therapeutics was founded in 2019 by Mauro Mileni.
Investors · 1
Related companies · 4
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
AlumisAlumis is a clinical-stage biopharmaceutical company developing a late-stage portfolio of targeted therapies for immune-mediated diseases. It focuses on small-molecule drug discovery and development in immunology and inflammation.
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Companies working in the same space as Abilita Therapeutics.
Frequently asked questions
- What does Abilita Therapeutics do?
- Abilita Therapeutics is a drug discovery company focused on membrane protein targets, using its EMP (Enabled Membrane Proteins) technology based on directed evolution to create stability- and expression-enhanced protein variants for discovering and optimizing drug candidates.
- Who founded Abilita Therapeutics?
- Abilita Therapeutics was founded by Mauro Mileni in 2019.
- Who are Abilita Therapeutics's investors?
- Abilita Therapeutics's investors include Two Bear Capital.
- Where is Abilita Therapeutics headquartered?
- Abilita Therapeutics is headquartered in San Diego, US.